Red Light Therapy to Reduce Inflammation: What the Evidence Actually Shows

Last updated: June 18, 2026 | 8-minute read

Red light therapy to reduce inflammation gets talked about constantly, but much of what you will read conflates wavelengths, overstates outcomes, or skips the biology entirely. The actual mechanism is specific, and the research behind photobiomodulation is more grounded than many marketing claims suggest.

Red and near-infrared light therapy, also called photobiomodulation, uses selected wavelengths of visible red and near-infrared light to interact with cellular photoacceptors, especially within mitochondria. Research suggests that appropriate doses may influence ATP production, oxidative stress signalling, and inflammatory mediators such as TNF-α, IL-1β, IL-6, and COX-2. However, results depend strongly on wavelength, irradiance, treatment distance, exposure time, tissue depth, and the condition being studied.

This guide explains how red and near-infrared light interact with living tissue, what the clinical evidence has measured, which wavelengths and power-density variables matter, and how to evaluate a device without relying on promotional claims.

What Is Red Light Therapy and How Does It Interact With Living Tissue?

Diagram showing red and near-infrared light penetrating skin layers into muscle and joint tissue

Red light therapy, formally called photobiomodulation (PBM), is the application of specific wavelengths of visible red light and near-infrared light to biological tissue to trigger cellular responses. It is not UV therapy, which can damage DNA. It is not laser ablation, which cuts or vaporises tissue. It is also not the same as an infrared heat lamp, which primarily works through thermal effects.

The fundamental mechanism of PBM is generally described as non-thermal. Photons in selected wavelength ranges are absorbed by light-sensitive molecules called chromophores inside cells. The best-known target is cytochrome c oxidase, an enzyme in the mitochondrial electron transport chain. This interaction may influence mitochondrial respiration, nitric oxide signalling, reactive oxygen species, and downstream inflammatory pathways.

According to the U.S. Food and Drug Administration's draft guidance on photobiomodulation devices and 510(k) submissions, PBM devices may fall under class II medical device categories depending on their intended use and product type. This does not mean every red light device is automatically approved for treating inflammation. It means that medical-device claims require appropriate regulatory pathways, evidence, testing, and labelling.

Two wavelength regions dominate much of the published PBM literature: visible red light around 630–660nm and near-infrared light around 800–850nm. Red light is more relevant for superficial tissues such as skin and fascia. Near-infrared light generally penetrates deeper and is more commonly discussed in relation to muscle, tendon, and joint-related applications.

In plain terms, red light therapy uses selected red and near-infrared wavelengths to influence cellular processes. It should be evaluated by wavelength, dose, treatment distance, exposure time, and safety documentation rather than by simple claims such as “stronger is better.”

The Biological Mechanism: How Red Light Therapy May Reduce Inflammation at the Cellular Level

Simplified cell diagram highlighting mitochondria cytochrome c oxidase activation and ATP production pathway

The primary cellular target discussed in PBM research is cytochrome c oxidase, an enzyme in the mitochondrial electron transport chain. Under cellular stress, nitric oxide can bind to cytochrome c oxidase and partially inhibit mitochondrial respiration. Red and near-infrared photons may help alter this interaction, supporting electron transport and ATP production.

Chung et al. describe the mechanisms and dose considerations of low-level laser and light therapy in “The Nuts and Bolts of Low-Level Laser (Light) Therapy”. De Freitas and Hamblin further review proposed PBM mechanisms in “Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy”.

Reactive Oxygen Species Modulation and Oxidative Stress

After light exposure, PBM may produce a brief, low-level change in reactive oxygen species. At appropriate doses, this is not necessarily damaging. Instead, it may act as a signalling event that activates adaptive antioxidant and repair pathways.

This response is often described as hormetic: a small, controlled stressor produces a beneficial adaptation. Hamblin discusses this concept in “Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation”.

Dose matters because PBM follows a biphasic dose-response pattern. Too little light may produce no measurable effect, while too much light may reduce or even reverse the desired response. This is why irradiance, distance, and exposure time are not minor details.

Pro-Inflammatory Cytokine Regulation

PBM research has reported changes in inflammatory mediators including TNF-α, IL-1β, IL-6, prostaglandins, and COX-2 in various experimental and clinical contexts. Some studies also describe increases in anti-inflammatory or resolution-related mediators.

This does not mean PBM works like a drug or guarantees the same results across every condition. Instead, it suggests that light exposure at appropriate parameters may influence biological pathways involved in inflammation, tissue repair, and pain modulation.

What the Clinical Evidence Shows

Clinical research on the treatment of inflammation with red light therapy

PBM has been studied across several inflammation-related conditions, including osteoarthritis, rheumatoid arthritis models, tendinopathy, post-surgical swelling, delayed-onset muscle soreness, wound healing, and inflammatory skin concerns. Evidence quality varies by condition, protocol, and study design.

A foundational review by Bjordal et al., “A Systematic Review of Low Level Laser Therapy With Location-Specific Doses for Pain From Chronic Joint Disorders”, found that low-level laser therapy at suggested dose ranges significantly reduced pain and improved health status in chronic joint disorders. This finding is important because it highlights dose dependence rather than a simple yes-or-no effect.

For knee osteoarthritis, a later systematic review and meta-analysis by Stausholm et al., “Efficacy of Low-Level Laser Therapy on Pain and Disability in Knee Osteoarthritis”, reported that LLLT reduced pain and disability at specific dose and wavelength ranges. However, different reviews have not always reached identical conclusions, partly because protocols, wavelengths, treatment points, and doses vary widely between trials.

For muscle recovery and exercise-related inflammation, PBM studies are mixed. Some research suggests improvements in recovery markers, soreness, or oxidative stress, while other trials show limited or no benefit under specific protocols. This reinforces the importance of not treating PBM as a universal recovery shortcut.

In practical terms, the evidence is strongest when PBM is used with clearly defined wavelengths, measured irradiance, appropriate dose, and consistent treatment schedules. It is weaker when products or articles make broad claims without explaining how the light is delivered to the target tissue.

What Wavelengths and Irradiance Levels Matter for Inflammation?

Tissue penetration depth comparison at 660nm vs 850nm vs 1060nm for red light therapy to reduce inflammation

Red and near-infrared light are commonly used because they fall within a wavelength region where tissue absorption and scattering may allow useful biological interaction. Below this range, melanin and haemoglobin absorb more light near the surface. Above the near-infrared range, water absorption becomes increasingly important.

Common PBM wavelengths include:

• 630–660nm red light: often used for skin, superficial inflammation, wound-healing research, and cosmetic dermatology applications.
• 800–850nm near-infrared light: often used for deeper tissue targets such as muscle, tendons, and joints.
• 904nm and related near-infrared wavelengths: used in some laser therapy studies, especially in musculoskeletal research.
• 1060nm and longer wavelengths: sometimes used in newer devices, though the clinical evidence base is less established for many inflammation-specific claims.

Irradiance, measured in mW/cm², is the power delivered per unit area. Dose, measured in J/cm², depends on irradiance and exposure time. A high wattage number on a product page is not enough to calculate dose. The useful number is irradiance at the actual treatment distance.

For example, a panel measured directly at the LED surface may appear much stronger than it is at 15cm or 30cm. Because light spreads over distance, treatment distance can dramatically change the dose that reaches the tissue. Any device intended for PBM should provide irradiance data at a named distance, not just total wattage or LED count.

The best-supported PBM protocols are specific. They define wavelength, power output, spot size or coverage area, dose per point or tissue area, session duration, frequency, and treatment schedule.

Localised vs Full-Body Inflammation: Matching Device Format to the Situation

Red light therapy products

Not all inflammation is the same, and not every device format fits every use case.

Localised inflammation, such as discomfort around a wrist tendon, knee area, or small patch of irritated skin, usually requires targeted delivery. A compact device may be suitable for small treatment areas if it provides adequate wavelength and dose information.

Larger-area applications, such as general muscle recovery across the back or legs, require broader coverage. Panels, mats, or arrays can cover larger regions, but they must still provide enough measurable irradiance at the actual treatment distance. More coverage does not automatically mean better treatment if the delivered dose is too low or poorly distributed.

The practical variables are:

• Target tissue depth: skin, fascia, muscle, tendon, joint capsule, or bone-adjacent tissue.
• Wavelength: red for more superficial targets, near-infrared for deeper targets.
• Distance: especially important for panels and lamps.
• Dose: calculated from irradiance and time.
• Frequency: consistent sessions usually matter more than occasional high-intensity exposure.
• Safety: eye protection, heat management, contraindications, and device quality.

For diagnosed inflammatory conditions, post-surgical recovery, severe pain, autoimmune disease, or ongoing joint disease, PBM should be discussed with a qualified healthcare professional rather than used as a stand-alone treatment plan.

How to Choose a Red Light Therapy Device for Anti-Inflammatory Use

Red light therapy device evaluation criteria checklist showing wavelength irradiance and certifications

Choosing a PBM device is not about finding the highest wattage or the most LEDs. It is about whether the device can deliver the right wavelength and dose to the target tissue safely and consistently.

1. Look for Specific Wavelengths

A credible device should list actual peak wavelengths, such as 630nm, 660nm, 810nm, 830nm, or 850nm. Broad claims such as “600–900nm therapy light” are less useful unless the manufacturer also gives specific LED or laser peak outputs.

2. Check Irradiance at Treatment Distance

The device should provide measured irradiance at a named distance, such as skin contact, 5cm, 15cm, or 30cm. For panels, a measurement at the LED surface is not enough because most users do not press panels directly against the skin.

3. Match Coverage Area to the Target

A small device may work for a wrist, ankle, or local skin area. A larger panel or mat may be more practical for back, thigh, or whole-body exposure. The device format should match the anatomical area rather than simply looking impressive.

4. Consider Dose Control

Useful controls include adjustable session time, power level, and clear instructions for distance and frequency. Without these, users may underdose or overdose without realising it.

5. Review Safety and Regulatory Documentation

Look for relevant testing documentation such as electrical safety, electromagnetic compatibility, photobiological safety, and appropriate regulatory status for the market where the device is sold. FDA establishment registration, CE marking, or similar documentation should not be confused with proof that a device treats a medical condition. Claims should match the evidence and the device's regulatory clearance or intended use.

Avoid any device that cannot provide wavelength data, irradiance at a named distance, basic safety documentation, or clear usage instructions.

Can Red Light Therapy Reduce Inflammation in the Skin and Face?

Red light therapy to reduce inflammation on the face using LED mask with visible red wavelength light

Skin and facial applications are among the most visible uses of LED and PBM devices because the target tissue is close to the surface. Acne-related redness, post-procedure inflammation, wound healing, and general skin rejuvenation have all been studied to varying degrees.

For acne, blue light around 415nm is often discussed because it can interact with porphyrins produced by acne-associated bacteria. A systematic review on blue-light therapy for acne vulgaris evaluated evidence for this approach. Earlier research also studied blue and red light combinations, including a trial using 415nm blue light and 660nm red light for acne treatment: “Phototherapy With Blue (415 nm) and Red (660 nm) Light in the Treatment of Acne Vulgaris”.

Red light around 630–660nm is commonly discussed for surface-level inflammation, redness, and tissue repair. Near-infrared light may reach somewhat deeper dermal structures, though facial devices should be evaluated carefully for eye safety and appropriate exposure.

The Cleveland Clinic notes that red light therapy shows promise for wrinkles, redness, acne, scars, and signs of ageing, while also emphasising that more clinical trials are needed to confirm effectiveness: Red Light Therapy: Benefits, Side Effects & Uses. Healthline similarly describes red light therapy as a form of phototherapy with potential uses but notes that more research is needed: Red Light Therapy: Is It Safe and Where Can You Get It?.

For facial use, eye protection and photobiological safety are especially important. Blue light, intense visible red light, and near-infrared light can all pose risks if used incorrectly or directed toward the eyes without protection.

What Color Light Is Best for Reducing Inflammation?

There is no single “best” colour for every type of inflammation.

Red light around 630–660nm is commonly used for superficial tissues, skin, and surface-level inflammatory concerns. Near-infrared light around 800–850nm is commonly used when the goal involves deeper structures such as muscle, tendons, or joints. Blue light around 415nm is more relevant to acne-related bacterial mechanisms than to deep musculoskeletal inflammation.

The correct wavelength depends on the target tissue, treatment goal, and device parameters. For many PBM applications, red and near-infrared wavelengths are combined because they address different tissue depths.

Key Takeaways

Red light therapy may help modulate inflammation through photobiomodulation mechanisms involving cytochrome c oxidase, mitochondrial signalling, reactive oxygen species, nitric oxide, and inflammatory mediators. However, effectiveness depends on wavelength, dose, irradiance, treatment distance, exposure time, and the condition being treated.

The strongest articles and studies do not claim that red light therapy is a universal cure. Instead, they show that PBM can produce measurable biological effects under specific conditions. For consumers and clinicians, the most important questions are not “How powerful is the device?” but “What wavelengths does it use, what dose reaches the tissue, and is the protocol supported by evidence?”

Frequently Asked Questions

What Color Light Is Best for Reducing Inflammation?

Red light around 630–660nm is commonly used for superficial inflammation involving the skin, fascia, and surface wounds. Near-infrared light around 800–850nm is more commonly used for deeper tissue targets such as muscle and joints. The best choice depends on tissue depth and the condition being addressed.

Does Red Light Therapy Work Immediately?

Some users may feel temporary comfort after a session, but inflammation-related outcomes in studies usually depend on repeated sessions over days or weeks. A single session should not be expected to resolve a chronic inflammatory condition.

Is More Power Always Better?

No. PBM follows a biphasic dose-response pattern, meaning too little light may have no effect and too much may reduce the intended benefit. Dose, distance, and exposure time should be controlled.

Is Red Light Therapy the Same as Infrared Heat Therapy?

No. Red light and near-infrared PBM are usually discussed as non-thermal or minimally thermal mechanisms. Far-infrared heat therapy works mainly through heat transfer and thermal effects.

Should Red Light Therapy Replace Medical Treatment?

No. PBM may be considered a supportive tool, but it should not replace medical care for arthritis, autoimmune disease, infection, injury, post-surgical swelling, or unexplained pain. Anyone with a diagnosed condition should consult a healthcare professional.

References & Sources

• Hamblin, M.R. “Mechanisms and Applications of the Anti-Inflammatory Effects of Photobiomodulation.” AIMS Biophysics, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5523874/
• Chung, H. et al. “The Nuts and Bolts of Low-Level Laser (Light) Therapy.” Annals of Biomedical Engineering, 2012. https://pubmed.ncbi.nlm.nih.gov/22045511/
• de Freitas, L.F. and Hamblin, M.R. “Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.” IEEE Journal of Selected Topics in Quantum Electronics, 2016. https://pubmed.ncbi.nlm.nih.gov/28070154/
• Bjordal, J.M. et al. “A Systematic Review of Low Level Laser Therapy With Location-Specific Doses for Pain From Chronic Joint Disorders.” Australian Journal of Physiotherapy, 2003. https://pubmed.ncbi.nlm.nih.gov/12775206/
• Stausholm, M.B. et al. “Efficacy of Low-Level Laser Therapy on Pain and Disability in Knee Osteoarthritis.” BMJ Open, 2019. https://pubmed.ncbi.nlm.nih.gov/31662383/
• U.S. Food and Drug Administration. “Photobiomodulation (PBM) Devices — Premarket Notification [510(k)] Submissions.” https://www.fda.gov/regulatory-information/search-fda-guidance-documents/photobiomodulation-pbm-devices-premarket-notification-510k-submissions
• Scott, A.M. et al. “Blue-Light Therapy for Acne Vulgaris: A Systematic Review and Meta-Analysis.” Annals of Family Medicine, 2019. https://pmc.ncbi.nlm.nih.gov/articles/PMC6846280/
• Papageorgiou, P. et al. “Phototherapy With Blue (415 nm) and Red (660 nm) Light in the Treatment of Acne Vulgaris.” British Journal of Dermatology, 2000. https://pubmed.ncbi.nlm.nih.gov/10809858/
• Cleveland Clinic. “Red Light Therapy: Benefits, Side Effects & Uses.” https://my.clevelandclinic.org/health/articles/22114-red-light-therapy
• Healthline. “Red Light Therapy: Is It Safe and Where Can You Get It?” https://www.healthline.com/health/red-light-therapy